- A new immunochemical faecal occult blood test (iFOBT) kit, and associated pathology services was introduced into the National Bowel Cancer Screening Program (the Program) in the first week of January 2018.
- The Program is a population based screening program that aims to help detect bowel cancer early and reduce the number of Australians who die each year from the disease. It commenced in 2006 and has been operating now for over 10 years. Eligible people aged 50 -74 years are invited by mail to complete a test kit at home and send it to the Program’s pathology laboratory for analysis. There is no cost involved.
- The new kit (an Eiken kit - OC Auto-sampling Bottle 3 - using the Pledia analyser) and associated pathology service was selected by the Department of Health through an open market tender process. The new kit is included on the Australian Register of Therapeutic Goods and is already used widely in Australia and overseas. The new pathology provider is Sonic Healthcare Limited (Sonic).
New Kit Resources
To support the introduction of the new kit a number of Program resources are available on-line, including:
Demonstration Kits can be ordered by emailing NBCSP@health.gov.au
New resources have recently been developed to support Indigenous participation in the Program, these include:
Promoting the NBCSP in your Practice
The Program saves lives – but it can only work with the support of general practices. The evidence is clear that a recommendation from a primary healthcare provider is an important motivator for participation in bowel cancer screening. Information and tips on promoting the Program in general practice can found in this fact sheet.
[Source: Department of Health]